FilingSEC EDGAR8-K
Emergent BioSolutions Announces CFO Transition
· SEC accepted
StageScheduled
Filing content
Emergent BioSolutions announced that CFO Richard S. Lindahl will retire effective December 31, 2026, and Frank Vargo will serve as interim CFO starting January 1, 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…